跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 5,737 条关于
“HWK-206”
全部
5,737
临床试验
2,222
药物
2,358
机构
54
资讯
1,103
3个月前
Whitehawk Therapeutics Validates SEZ6 as High-Expression Target for Small Cell Lung Cancer ADC Development
5天前
Whitehawk Data at WCLC 2026 Position PTK7 as Durable, Treatment-Agnostic ADC Target in EGFR Wild-Type NSCLC
6个月前
Amgen Completes Phase 3 Trial for ABP 206 Opdivo Biosimilar in Advanced Melanoma
8个月前
Whitehawk Therapeutics Advances Two Next-Generation ADCs into Clinical Trials with FDA IND Clearances
3个月前
CorrectSequence's Base-Editing Therapy CS-206 Shows 15-Month VOC-Free Success in Sickle Cell Disease Patient
10个月前
Whitehawk Therapeutics Validates PTK7 as Third Most Abundant ADC Target Across 157,000 Tumor Samples
去年
Biohaven's Troriluzole Shows Promise in Slowing Spinocerebellar Ataxia Progression
去年
Caliway Biopharmaceuticals Secures Record-Breaking $206M IPO, Advances Novel Fat Reduction Drug Development
9个月前
Bristol-Myers Squibb and BioNTech Launch Phase 1/2 Trial Testing Pumitamig in First-Line Hepatocellular Carcinoma
去年
PTAB Director Denies Amgen's IPR Challenges Against Bristol Myers Squibb's Opdivo Patents Based on Settled Expectations
第 1 页,共 111 页
上一页
下一页